A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.

Key facts

Study ID

NCT07433179

Run by

Septerna, Inc.

People needed

150

Starts

2026-03-04

Expected to finish

2027-02-01

Last updated by the study team

2026-04-22

Who can join

Age: 21 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects who are able and willing to provide informed consent
• Aged 21 to 60 years at the time of consent
• Have a BMI within the range 18.0 to 32.0 kg/m2
• In general good health

You may not qualify if…

• Any condition, which in the investigator's opinion might jeopardize participant's safety or compliance with the protocol.
• Have clinically significant abnormalities on clinical laboratory results.
• Participation in other clinical trials recently/currently

Where it is running

• Nucleus Network — Melbourne, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.